Mendelian randomization study of eczema and depression
-
摘要:
目的 湿疹与抑郁症之间的关系备受关注,然而二者之间的因果关联尚不明确。本研究采用孟德尔随机法(MR)研究湿疹与抑郁症之间是否存在因果关系。 方法 在公开的全基因组关联研究(GWAS)的集合数据集中选出湿疹与抑郁症的基因型数据,湿疹为暴露因素,抑郁症为结局变量。样本量为40 835例。利用MR对所选样本进行基因型分析,其中工具变量为与湿疹疾病有强相关性的基因位点。采用比值比(OR)作为估计指标,效应值β判断两者之间的关联方向。同时进行异质性检验、敏感性分析以及水平多效性检验。 结果 逆方差加权法分析结果显示,湿疹与抑郁发生之间呈正相关关系(OR=1.011,95% CI:1.001~1.022,P=0.037);加权中位数回归分析得到了相似结果(OR=1.012,95% CI: 1.001~1.023,P=0.029)。Cochran's Q检验显示结果存在显著异质性(P < 0.05),但通过随机效应模型分析得到P=0.037且β=0.011,证明二者存在正向因果关系。此外,漏斗图和Mr-Egger截距未观察到水平多效性。 结论 研究结果表明,湿疹与抑郁发生之间可能存在正向因果关系。 Abstract:Objective The relationship between eczema and depression has received much attention, yet the causal association between the two is unclear. Therefore, Mendelian randomization (MR) was used to investigate whether there is a causal relationship between eczema and depression. Methods Genotypic data of eczema and depression were selected from the publicly available pooled dataset of the Genome-wide association study (GWAS), with eczema as the exposure factor and depression as the outcome variable. The selected samples were genotyped using MR, where the instrumental variables were genetic loci with a strong correlation with eczema disease. The odds ratio (OR) was used as an estimator, and the effect value β judged the direction of the association between the two. Heterogeneity test, sensitivity analysis, and horizontal multiple validity test were also performed. Results Inverse variance weighted method analysis showed a positive correlation between eczema and the occurrence of depression and yielded an OR of 1.011, 95% CI: 1.001-1.022, P=0.037; weighted median regression analysis yielded similar results (OR=1.012, 95% CI: 1.001-1.023, P=0.029). Cochran ' s Q test showed significant heterogeneity of the results (P < 0.05), but the analysis of the random effects model yielded P=0.037 and β=0.011, which proved that there was a positive causal relationship. In addition, no horizontal pleiotropy was observed for the funnel plot and Mr-Egger intercept. Conclusion The findings suggest a possible positive causal relationship between eczema and the occurrence of depression. -
Key words:
- Eczema /
- Depression /
- Mendelian randomization
-
表 1 样本基本信息
Table 1. Sample basic information
暴露/结局 GWAS号 病例(例) 对照(例) SNP数量 人群 年份 湿疹 ieu-a-996 10 788 30 047 11 059 641 European 2014年 抑郁症 ukb-d-20544_11 25 087 92 695 13 571 547 European 2018年 注:SNP为单核苷酸多态性(single nucleotide polymorphism)。 表 2 孟德尔随机化分析结果
Table 2. Results of mendelian randomization analysis
方法 效应值 P值 OR值 OR_lci95 OR_uci95 MR Egger 0.010 0.529 1.010 0.980 1.041 Weighted median 0.012 0.029 1.012 1.001 1.023 Inverse variance weighted 0.011 0.037 1.011 1.001 1.022 Simple mode 0.013 0.147 1.013 0.997 1.029 Weighted mode 0.011 0.141 1.012 0.997 1.026 -
[1] 麦卫华, 刘岳花, 陆东庆. Th17细胞相关细胞因子IL-17/IL-23与湿疹发病及病情严重程度的关系[J]. 中华全科医学, 2017, 15(12): 2056-2058, 2132. doi: 10.16766/j.cnki.issn.1674-4152.2017.12.015MAI W H, LIU Y H, LU D Q. The associations of Th17 cell-relevant cytokines IL-17/IL-23 with the pathogenesis and disease severity of eczema[J]. Chinese Journal of General Practice, 2017, 15(12): 2056-2058, 2132. doi: 10.16766/j.cnki.issn.1674-4152.2017.12.015 [2] 陆慧慧, 高迎霞, 张倩莹, 等. 基于患者报告的特应性皮炎患者生活质量测量工具的研究进展[J]. 皮肤性病诊疗学杂志, 2023, 30(4): 360-365.LU H H, GAO Y X, ZHANG Q Y, et al. Update of patient-reported quality-of-life measurement instruments for patients with atopic dermatitis[J]. Journal of Diagnosis and Therapy on Dermato-venereology, 2023, 30(4): 360-365. [3] DE LUSIGNAN S, ALEXANDER H, BRODERICK C, et al. The epidemiology of eczema in children and adults in England: a population-based study using primary care data[J]. Clin Exp Allergy, 2021, 51(3): 471-482. doi: 10.1111/cea.13784 [4] TREUDLER R, ZEYNALOVA S, RIEDEL-HELLER S G, et al. Depression, anxiety and quality of life in subjects with atopic eczema in a population-based cross-sectional study in Germany[J]. J Eur Acad Dermatol Venereol, 2020, 34(4): 810-816. doi: 10.1111/jdv.16148 [5] BAO Q, CHEN L, LU Z, et al. Association between eczema and risk of depression: a systematic review and meta-analysis of 188, 495 participants[J]. J Affective Disord, 2018, 238: 458-464. doi: 10.1016/j.jad.2018.05.007 [6] SCHMITT J, APFELBACHER C, CHEN C M, et al. Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus)[J]. J Allergy Clin Immunol, 2010, 125(2): 404-410. doi: 10.1016/j.jaci.2009.10.055 [7] YAGHMAIE P, KOUDELKA C W, SIMPSON E L. Mental health comorbidity in patients with atopic dermatitis[J]. J Allergy Clin Immunol, 2013, 131(2): 428-433. doi: 10.1016/j.jaci.2012.10.041 [8] DAVIES N M, HOLMES M V, SMITH G D. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians[J]. BMJ, 2018, 362: k601. DOI: 10.1136/bmj.k601. [9] NOLTE I M. Metasubtract: an R-package to analytically produce leave-one-out meta-analysis GWAS summary statistics[J]. Bioinformatics, 2020, 36(16): 4521-4522. doi: 10.1093/bioinformatics/btaa570 [10] 邓俊峰, 楼芳, 焦继光. 皮炎湿疹疾病进展与皮损微生物感染种类、数量及炎性因子的关联研究[J]. 河北医药, 2017, 39(6): 865-867.DENG J F, LOU F, JIAO J G. Association between the progression of dermatitis eczema and the types, quantities and inflammatory factors of microbial infections in skin lesions[J]. Hebei Medical Journal, 2017, 39(6): 865-867. [11] DALGARD F J, GIELER U, TOMAS-ARAGONES L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries[J]. J Invest Dermatol, 2015, 135(4): 984-991. doi: 10.1038/jid.2014.530 [12] KIM S H, HUR J, JANG J Y, et al. Psychological distress in young adult males with atopic dermatitis: a cross-sectional study[J]. Medicine, 2015, 94(23): e949. DOI: 10.1097/MD.0000000000000949. [13] MIZARA A, PAPADOPOULOS L, MCBRIDE S R. Core beliefs and psychological distress in patients with psoriasis and atopic eczema attending secondary care: the role of schemas in chronic skin disease[J]. Br J Dermatol, 2012, 166(5): 986-993. doi: 10.1111/j.1365-2133.2011.10799.x [14] HON K L, PONG N H, POON T C W, et al. Quality of life and psychosocial issues are important outcome measures in eczema treatment[J]. J Dermatol Treat, 2015, 26(1): 83-89. doi: 10.3109/09546634.2013.873762 [15] RIED J S, LI J, ZUO X B, et al. Multi-ancestry genome-wide association study of 21, 000 cases and 95, 000 controls identifies new risk loci for atopic dermatitis[J]. Nat Genet, 2015, 47(12): 1449-1456. doi: 10.1038/ng.3424 [16] KIM J H, LEE S Y, KANG M J, et al. Association of genetic polymorphisms with atopic dermatitis, clinical severity and total IgE: a replication and extended study[J]. Allergy Asthma Immunol Res, 2018, 10(4): 397-405. doi: 10.4168/aair.2018.10.4.397 [17] CHANG X, MARCH M, MENTCH F, et al. A genome-wide association meta-analysis identifies new eosinophilic esophagitis loci[J]. J Allergy Clin Immunol, 2022, 149(3): 988-998. doi: 10.1016/j.jaci.2021.08.018 [18] MARENHOLZ I, GROSCHE S, KALB B, et al. Genome-wide association study identifies the SERPINB gene cluster as a susceptibility locus for food allergy[J]. Nature Communications, 2017, 8(1): 1056. DOI: 10.1038/s41467-017-01220-0. [19] WANG X, ZHU Y F, LI D M, et al. Polymorphisms of ST 2-IL 18R1-IL 18 RAP gene cluster: a new risk for autoimmune thyroid diseases[J]. Int J Immunogenet, 2016, 43(1): 18-24. doi: 10.1111/iji.12240 [20] MARTÍNEZ-AGUILAR N E, DEL RÍO-NAVARRO B E, NAVARRO-OLIVOS E, et al. SPINK5 and ADRB2 haplotypes are risk factors for asthma in Mexican pediatric patients[J]. J Asthma, 2015, 52(3): 232-239. doi: 10.3109/02770903.2014.966913 [21] 李昕哲, 路越. 复方荆芥熏洗剂治疗肛周湿疹的相关机制及优势概述[J]. 中国医药, 2023, 18(7): 1112-1116.LI X Z, LU Y. Summary of the related mechanisms and advantages of compound schizonepeta herb fumigant in the treatment of perianal eczema[J]. China Medicine, 2023, 18(7): 1112-1116. [22] LI H, CUI Q K, LI Z, et al. Clinical observation of the effect of modified Ginseng-Schisandra decoction (MGSD) on trace elements and immune function in children with spleen deficiency syndrome after recurrent respiratory tract infection (RRTI): a randomized controlled trial[J]. Transl Pediatr, 2021, 10(6): 1692-1700. doi: 10.21037/tp-21-243 [23] BEUREL E, TOUPS M, NEMEROFF C B. The bidirectional relationship of depression and inflammation: double trouble[J]. Neuron, 2020, 107(2): 234-256. doi: 10.1016/j.neuron.2020.06.002 [24] HAN Q Q, LI W H, CHEN P Q, et al. Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression[J]. Neural Regen Res, 2024, 19(9): 1890-1898. doi: 10.4103/1673-5374.390964 [25] WANG H, HE Y, SUN Z, et al. Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression[J]. J Neuroinflammation, 2022, 19(1): 132. doi: 10.1186/s12974-022-02492-0 [26] JIA X, GAO Z, HU H. Microglia in depression: current perspectives[J]. Sci China Life Sci, 2021, 64(9): 911-925. [27] HAYLEY S, HAKIM A M, ALBERT P R. Depression, dementia and immune dysregulation[J]. Brain, 2021, 144(3): 746-760. doi: 10.1093/brain/awaa405